Co-Authors
This is a "connection" page, showing publications co-authored by Alain Combes and Marc Pineton de Chambrun.
Connection Strength
2.760
-
Response to Letter: 'Reply to "High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?"'. J Intern Med. 2021 03; 289(3):427-429.
Score: 0.903
-
High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability? J Intern Med. 2021 03; 289(3):422-424.
Score: 0.892
-
Clarkson's Disease Episode or Secondary Systemic Capillary Leak-Syndrome: That Is the Question! Chest. 2021 01; 159(1):441.
Score: 0.230
-
Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units. Chest. 2021 02; 159(2):657-662.
Score: 0.225
-
SARS-CoV-2 Induces Acute and Refractory Relapse of Systemic Capillary Leak Syndrome (Clarkson's Disease). Am J Med. 2020 11; 133(11):e663-e664.
Score: 0.220
-
Outcomes of Patients Denied Extracorporeal Membrane Oxygenation during the COVID-19 Pandemic in Greater Paris, France. Am J Respir Crit Care Med. 2021 Oct 15; 204(8):994-997.
Score: 0.061
-
Extracorporeal Membrane Oxygenation Induces Early Alterations in Coagulation and Fibrinolysis Profiles in COVID-19 Patients with Acute Respiratory Distress Syndrome. Thromb Haemost. 2021 Aug; 121(8):1031-1042.
Score: 0.059
-
Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: a retrospective cohort study. Ann Intensive Care. 2020 Nov 23; 10(1):158.
Score: 0.057
-
Response to: 'Presence of anti-phospholipid antibodies in COVID-19: a case series study' by Amezcua-Guerra et al. Ann Rheum Dis. 2021 05; 80(5):e74.
Score: 0.056
-
Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study. Circulation. 2020 08 11; 142(6):611-614.
Score: 0.055